Prete M - Search Results

1

Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma.

Lamanuzzi A, Saltarella I, Desantis V, Frassanito MA, Leone P, Racanelli V, Nico B, Ribatti D, Ditonno P, Prete M, Solimando AG, Dammacco F, Vacca A, Ria R. Lamanuzzi A, et al. Among authors: prete m. Oncotarget. 2018 Apr 17;9(29):20563-20577. doi: 10.18632/oncotarget.25003. eCollection 2018 Apr 17. Oncotarget. 2018. PMID: 29755672 Free PMC article.

2

Clinical characteristics of obese patients with adult-onset Still's disease. Data from a large multicentre cohort.

Di Cola I, Iacono D, Pantano I, Mauro D, Vitale A, Caso F, De Stefano L, Prete M, Navarini L, Ciaffi J, Ursini F, Costa L, Perosa F, Montecucco C, Cantarini L, Frediani B, Ciccia F, Giacomelli R, Cipriani P, Ruscitti P. Di Cola I, et al. Among authors: prete m. Joint Bone Spine. 2023 Sep;90(5):105576. doi: 10.1016/j.jbspin.2023.105576. Epub 2023 Apr 18. Joint Bone Spine. 2023. PMID: 37080283 Free article.

3

Increased serum levels of beta2m-free HLA class I heavy chain in multiple myeloma.

Perosa F, Luccarelli G, Prete M, Ferrone S, Dammacco F. Perosa F, et al. Among authors: prete m. Br J Haematol. 1999 Sep;106(4):987-94. doi: 10.1046/j.1365-2141.1999.01635.x. Br J Haematol. 1999. PMID: 10520002 Free article.

4

Serum levels of beta-2-microglobulin-free heavy chain of HLA class I antigen in healthy individuals: relationship to their class I allotype.

Perosa F, Prete M, Luccarelli G, Favoino B, Ferrone S, Dammacco F. Perosa F, et al. Among authors: prete m. Hum Immunol. 1999 Nov;60(11):1058-66. doi: 10.1016/s0198-8859(99)00081-6. Hum Immunol. 1999. PMID: 10600003

5

Human CD4 internal antigen anti-idiotypic monoclonal antibody. immunochemical and sequence analysis.

Perosa F, Luccarelli G, Prete M, Indiveri F, Dammacco F. Perosa F, et al. Among authors: prete m. Clin Exp Med. 2001 Jun;1(2):81-9. doi: 10.1007/s10238-001-8016-1. Clin Exp Med. 2001. PMID: 11699732

6

Monoclonal antibodies in the immunotherapy of autoimmune diseases.

Perosa F, Luccarelli G, Prete M, Dammacco F. Perosa F, et al. Among authors: prete m. Ann Ital Med Int. 2001 Oct-Dec;16(4):220-32. Ann Ital Med Int. 2001. PMID: 11799630 Review.

7

Beta-2 microglobulin-free HLA class I heavy chain (FHC) A3 and/or A30 soluble products contribute only minimally to serum FHC expression.

Perosa F, Prete M, Luccarelli G, Favoino B, Dammacco F. Perosa F, et al. Among authors: prete m. Eur J Immunogenet. 2002 Oct;29(5):409-12. doi: 10.1046/j.1365-2370.2002.00343.x. Eur J Immunogenet. 2002. PMID: 12358850

8

Biological therapy with monoclonal antibodies: a novel treatment approach to autoimmune disease.

Prete M, Perosa F, Favoino E, Dammacco F. Prete M, et al. Clin Exp Med. 2005 Dec;5(4):141-60. doi: 10.1007/s10238-005-0080-5. Clin Exp Med. 2005. PMID: 16362794 Review.

9

Rheumatic disorders as paraneoplastic syndromes.

Racanelli V, Prete M, Minoia C, Favoino E, Perosa F. Racanelli V, et al. Among authors: prete m. Autoimmun Rev. 2008 May;7(5):352-8. doi: 10.1016/j.autrev.2008.02.001. Epub 2008 Feb 22. Autoimmun Rev. 2008. PMID: 18486921 Review.

10

CD20-depleting therapy in autoimmune diseases: from basic research to the clinic.

Perosa F, Prete M, Racanelli V, Dammacco F. Perosa F, et al. Among authors: prete m. J Intern Med. 2010 Mar;267(3):260-77. doi: 10.1111/j.1365-2796.2009.02207.x. J Intern Med. 2010. PMID: 20201920 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

361 results

Search Page

Filters